Personal Information
Entreprise/Lieu de travail
Greater Boston Area United States
Profession
Director, Innovation Sourcing at Boehringer Ingelheim
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
Outcome driven biotechnology leader, recognized for delivering innovation and being creative, dynamic, and cross functionally capable. Extensive experience covering business development, alliance management, partnering and licensing activities in diagnostics, personalized medicine, therapeutics, and technology platforms with proven track record from Genzyme Genetics, Millennium Pharmaceuticals, MassBio, and T1D Exchange.
Possess strong business acumen, critical thinking, negotiations and sophisticated quantitative tools to illuminate business and technology opportunities, structure and negotiate deals, analyze intellectual property and understand financial exposure for drug development p...
Mots-clés
clinic networks
clinical trial
patients
patient registry
services
business development
innovation
biotechnology
start-up
entrepreneurship
technology
venture
Tout plus
Présentations
(4)J’aime
(1)Understanding Risk & Uncertainty
Kelvin Stott
•
il y a 12 ans
Personal Information
Entreprise/Lieu de travail
Greater Boston Area United States
Profession
Director, Innovation Sourcing at Boehringer Ingelheim
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
Outcome driven biotechnology leader, recognized for delivering innovation and being creative, dynamic, and cross functionally capable. Extensive experience covering business development, alliance management, partnering and licensing activities in diagnostics, personalized medicine, therapeutics, and technology platforms with proven track record from Genzyme Genetics, Millennium Pharmaceuticals, MassBio, and T1D Exchange.
Possess strong business acumen, critical thinking, negotiations and sophisticated quantitative tools to illuminate business and technology opportunities, structure and negotiate deals, analyze intellectual property and understand financial exposure for drug development p...
Mots-clés
clinic networks
clinical trial
patients
patient registry
services
business development
innovation
biotechnology
start-up
entrepreneurship
technology
venture
Tout plus